# Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study

> **NCT05053100** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 100 (actual)

## Conditions studied

- Acute Leukemia
- Deep Vein Thrombosis
- Hematopoietic and Lymphoid Cell Neoplasm
- Hodgkin Lymphoma
- Myeloproliferative Neoplasm
- Non-Hodgkin Lymphoma
- Plasma Cell Myeloma
- Thrombocytopenia

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT05053100
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-17
- **Primary completion:** 2024-07-05
- **Final completion:** 2024-07-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05053100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05053100, "Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05053100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*